exhibit 10. 1 schedule of investors to securities purchase agreement, by and among aveo pharmaceuticals, inc. and the investors set forth therein, dated as of october 28, 2010 investor number of shares purchased number of shares purchased total purchase price janus investment fund on behalf of its series janus global life sciences fund janus capital funds plc on behalf of its sub - fund janus global life sciences fund healthcor, l. p. healthcor offshore master fund, l. p. healthcor hybrid offshore master fund, l. p. alyeska master fund, l. p. ( entity name, alyeska investment group, l. p. ) deutsche bank ag london fidelity advisor series i : fidelity advisor dividend growth fund fidelity advisor series i : fidelity advisor balanced fund fidelity select portfolios : health care portfolio variable insurance products fund ii : contrafund portfolio fidelity puritan trust : fidelity balanced fund fidelity securities fund : fidelity dividend growth fund fidelity destiny portfolios : fidelity advisor capital development fund fidelity advisor series vii : fidelity advisor health care fund variable insurance products fund iv : health care portfolio fidelity central investment portfolios llc : fidelity health care central fund variable insurance products fund iii : balanced portfolio fidelity devonshire trust : fidelity series all - sector equity fund baupost group securities, l. l. c. plutus holdings 2 ltd total securities purchase agreement this securities purchase agreement ( this “ agreement ” ) is made and entered into as of october 28, 2010 by and among aveo pharmaceuticals, inc., a delaware corporation ( the “ company ” ), and the investors set forth on the signature pages affixed hereto ( each an “ investor ” and collectively the “ investors ” ). recitals a. the company and the investors are executing and delivering this agreement in reliance upon the exemption from securities registration afforded by the provisions of regulation d ( “ regulation d ” ), as promulgated by the u. s. securities and exchange commission ( the “ sec ” ) under the securities act of 1933, as amended ; and b. the investors wish to purchase from the company, and the company wishes to sell and issue to the investors, upon the terms and subject to the conditions stated in this agreement, shares ( the “ shares ” ) of the company ’ s common stock, par value $ 0. 001 per share ( the “ common stock ” ) at a purchase price of $ 13. 50 per share ( the “ purchase price ” ). c.